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Little is currently known about proteins that make contact with the pre-mRNA in the U12-dependent
spliceosome and thereby contribute to intron recognition. Using site-specific cross-linking, we detected an
interaction between the U11-48K protein and U12-type 5 splice sites (5ss). This interaction did not require
branch point recognition and was sensitive to 5ss mutations, suggesting that 48K interacts with the 5ss
during the first steps of prespliceosome assembly in a sequence-dependent manner. RNA interference-induced
knockdown of 48K in HeLa cells led to reduced cell growth and the inhibition of U12-type splicing, as well as
the activation of cryptic, U2-type splice sites, suggesting that 48K plays a critical role in U12-type intron
recognition. 48K knockdown also led to reduced levels of U11/U12 di-snRNP, indicating that 48K contributes
to the stability and/or formation of this complex. In addition to making contact with the 5ss, 48K interacts with
the U11-59K protein, a protein at the interface of the U11/U12 di-snRNP. These studies provide important
insights into the protein-mediated recognition of the U12-type 5ss, as well as functionally important interac-
tions within the U11/U12 di-snRNP.
Most metazoans and some unicellular eukaryotes contain
two distinct spliceosomes (reference 28 and references
therein). The majority of introns are excised by the major,
U2-dependent spliceosome, while a subset (0.5%) with
highly conserved 5 splice sites (5ss) and branch point se-
quences (BPS) are removed by the minor, U12-dependent
spliceosome (for a review, see reference 24). Both spliceo-
somes consist of five small nuclear ribonucleoprotein particles
(snRNPs) and numerous non-snRNP proteins. The two spli-
ceosomes share the U5 snRNP, while the remaining four
snRNPs in each spliceosome are distinct but functionally anal-
ogous, with U11, U12, U4atac, and U6atac of the minor spli-
ceosome being the counterparts of U1, U2, U4, and U6 in the
major spliceosome, respectively (12, 14, 16, 34, 35, 42).
Intron recognition is achieved via multiple, dynamic RNA-
and protein-mediated interactions. RNA-RNA interactions in
the two spliceosomes are highly analogous. In the major spli-
ceosome, the first assembly step (generating the E complex)
involves the recognition of the 5ss by U1, while the non-
snRNP protein factors SF1, U2AF65, and U2AF35 bind to the
BPS, the polypyrimidine tract, and the 3ss, respectively (for a
review, see reference 26). During this stage, U1 base pairs with
the pre-mRNA’s 5ss, while U1-associated proteins facilitate
5ss recognition or stabilize the U1-5ss complex (for a review,
see reference 37). During prespliceosome (A complex) forma-
tion, U2 associates stably with the BPS (17), while non-snRNP
proteins bridge U1 and U2 snRNPs (40, 41). The U4/U6/U5
tri-snRNP then joins the spliceosome (generating the B com-
plex), which triggers the displacement of U1 from the 5ss by
U6 and additional rearrangements that lead to catalytic core
formation (for a review, see references 22 and 33).
The overall assembly pathway of the minor spliceosome is
similar. Initially, U11 base pairs with the 5ss and U12 base
pairs with the BPS (16, 35, 42). U11 is displaced from the 5ss
by U6atac after the association of the U4atac/U6atac/U5 tri-
snRNP, and this displacement is followed by additional rear-
rangements that result in a catalytic core with an architecture
highly similar to that of the major spliceosome (9, 14, 32).
However, intriguing differences during the initial intron recog-
nition step are observed. For example, U12-type E complexes
have not been detected. Instead, the 5ss and BPS are recog-
nized cooperatively by a preformed U11/U12 di-snRNP (10,
36), suggesting that components connecting the 5ss and the
BPS are already present in the di-snRNP prior to prespliceo-
some formation. The initial base-pairing interactions at the
5ss in the two spliceosomes are also different. The U1-5ss
interaction spans nucleotides (nt) 2 or 1 through 6 rela-
tive to the 5ss both in mammals and in Saccharomyces cerevi-
siae (see Fig. 1B and C). In contrast, the first three nucleotides
of U12-type introns (RUA) do not engage in base pairing with
either U11 or U6atac snRNAs (see Fig. 1A), but their identi-
ties are almost 100% conserved (31). Mutations in the 1 and
2 positions block U12-dependent splicing and lead to the
activation of cryptic splice sites (2). This observation suggests
that a protein interacts with the RUA motif in a sequence-
specific manner during intron recognition.
In addition to Sm proteins, the human 18S U11/U12 di-
snRNP comprises SF3b, a heptameric protein complex also
present in U2 snRNPs, plus seven proteins not found in the
major spliceosome (38). Four of the latter (59K, 48K, 35K, and
25K) are associated with the 12S U11 snRNP and thus poten-
tially play an important role in 5ss recognition and/or prespli-
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ceosome assembly. The 59K protein, via its interaction with the
U12-associated 65K protein, appears to be involved in di-
snRNP formation (1). The role of the other U11-associated
proteins is currently unknown.
Here, we show that the 48K protein makes direct contact
with the 2 position of the U12-type 5ss, demonstrating for
the first time an interaction between a U11 protein and the
pre-mRNA. In addition, we provide evidence that 48K is es-
sential for the splicing of U12-type introns in vivo and also
contributes to U11/U12 di-snRNP formation and stability, po-
tentially by interacting with the di-snRNP interface protein
U11-59K.
MATERIALS AND METHODS
Oligonucleotides. DNA oligonucleotides were purchased from Sigma-Aldrich
or from Oligomer Oy. 2-O-Methyl (2ome) RNA oligonucleotides and 2ome
DNA chimeric oligonucleotides were purchased from the Keck Oligonucleotide
Synthesis Facility at Yale University or from Proligo. Small interfering RNA
(siRNA) oligonucleotides were synthesized in-house or obtained from Qiagen.
The 2ome oligonucleotides used for the pretreatment of nuclear extracts were as
follows: U2b, used to block U2-dependent splicing (18); U6atac1–20, used to
arrest U12-dependent spliceosome assembly at the A complex stage (34); and
U12a, used to block the U12-BPS interaction (9, 35). DNA oligonucleotides used
for cloning intron 9 of the mouse Vps16 gene were Vps16-1 (AGGAAAGGGC
TGTTGTTGTG) and Vps16-2 (CTTCATGCAGGAACTCATGG), and those
for generating the template for the in vitro transcription of the Vps16 substrates
were Vps16-7 (GCGAAGCTTAATACGACTCACTATAGGGAAAGGGCTG
TTGTTGTGG) and Vps16-8 (TACTTACCTTCATGCAGGAACTCATGG).
DNA oligonucleotides used for RNase H assays were P120-13 and P120-26 (10),
which are complementary to the 5ss (nt 4 through 10) and intron (nt 90
through 103) of the wild-type (WT) P120 construct, and P120-182 and P120-
193, which are essentially similar to P120-13, with appropriate changes to com-
plement the mutations CC56GG and A3G in the P120 mutant substrates,
respectively. The following 21-nt siRNA duplexes with 2-nt deoxyribosylthymine
(dT) 3-end overhangs were used for RNA interference (RNAi; only the sense
strand sequence is shown) and were annealed as described previously (7): BB1
(targeting the fly luciferase gene; CGTACGCGGAATACTTCGA-dT-dT),
139-1 (targeting the 48K open reading frame; CGGTTTGTTTGTGATCTAA-
dT-dT), and CT2 (targeting the human Prp8 [hPrp8] gene 3 untranslated region;
GGCCGCTGACATTCAGCAG-dT-dT). Quantitative real-time PCR (qRT-
PCR) analysis of siRNA-targeted mRNAs was carried out using the following
gene-specific primers: 48Kfor (specific for exons 7 and 8; GATGCCGAAAAG
AATGAAGAAAG), 48Krev (specific for exon 8; TGGGCTTCTACTCCTATC
CCTTC), GLUD2for (TCGTGGAGGACAAGTTGGTG), and GLUD2rev (T
TGCAGGGCTTGATGATCCG). The RT-PCR primers used to detect the
effect of siRNA-induced knockdown on splicing are described in Table S1 in the
supplemental material, along with their target introns.
Plasmids. For the construction of pVps16-i9, the last 70 nt of exon 9, intron 9,
and the first 89 nt of exon 10 of the mouse Vps16 gene (Ensembl release 36
accession no. ENSMUSG00000027411; www.ensembl.org) were amplified by
PCR from genomic mouse (strain Sv129) DNA. This fragment was then inserted
into pCRII-TOPO. For the production of RNA site-specifically labeled with
4-thiouridine (4SU), plasmid pVps16-e9m was constructed, in which nt 70 to
2 (relative to the 5ss) of pVps16 were modified to contain a T residue solely
at position 2, similar to the construction of the previously described P120
cross-linking substrate (8, 9). The mutations CC56GG and A3G were
introduced into pP120 (35) and pVps16-i9 by PCR and verified by sequencing.
Splicing substrates. Capped pre-mRNA substrates uniformly labeled with 32P
were produced by in vitro transcription as described previously (9). For cross-
linking, substrates containing a 4SU residue and/or a 32P phosphate group at a
specific site were constructed using the two-piece RNA ligation protocol (9).
Substrates lacking the BPS were truncated 3 nt upstream of the BPS.
In vitro spliceosome assembly and splicing. In vitro splicing was performed as
described previously (21), except that the concentration of the U2b oligonucle-
otide was 2.4 M. Polyvinyl alcohol (1.0%) was used in all reaction mixtures
except those subjected to native-gel analyses and RNase H protection assays.
The concentrations of splicing substrates were 2 nM for native-gel analyses,
RNase H protection assays, and splicing assays and 10 nM for cross-linking
experiments. To deplete ATP, ATP and creatine phosphate were omitted and
the reaction mixture was preincubated for 30 min before the addition of the
substrate. To deplete Mg2, MgCl2 was omitted and 2.5 mM EDTA was added.
Blocking with 2ome oligonucleotides, RNase H assays, and native-gel analyses
were performed as described in reference 10, and Northern blot analyses were
performed as described in reference 35.
Cross-linking. For 4SU cross-linking, 5 to 20 l of a splicing reaction mixture
was irradiated for 3 min with a 337-nm N2 excimer laser (PSX-100; Neweks Ltd.,
Estonia) and then subjected to treatment with a nuclease mixture (0.01 mg of
micrococcal nuclease/ml, 0.02 U of RNase T1/l, 0.1 mg of RNase A/ml) at 37°C
for 30 min. Proteins were separated by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE; on a 4 to 12% NuPAGE or 8 to 16% Precise
protein gel) and detected by autoradiography or phosphorimager (Fuji FLA-
5010) analysis.
IPs. Rabbit antibodies against the U11/U12 25K, 35K, 48K, 59K, and 65K
proteins and SF3b49 were raised as described previously (6, 38). Twenty-micro-
liter aliquots of affinity-purified antibody or serum (in the case of anti-48K and
anti-SF3b49) were preabsorbed to 20 l of protein A-Sepharose beads in 200 l
of 100 mM Tris-HCl (pH 8.0)–phosphate-buffered saline (PBS) overnight at 4°C.
Beads were washed three times with PBS, and 20 l of a UV-treated splicing
reaction mixture was added. Samples were either left in their native state or
FIG. 1. RNA-RNA interactions at the 5ss. (A) Base-pairing interactions between the U12-type 5ss and the human U11 and U6atac snRNAs.
The putative protein binding site is shaded. (B and C) Base pairing of the human (B) and yeast (C) U2-type 5ss with U1 and U6. The sequence
recognized by the yeast U1 C protein is shaded.  denotes a pseudouridine residue, and 3m Gppp indicates the trimethylguanosine cap.
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treated with RNases and denatured at 95°C for 2 min in the presence of 0.15%
SDS prior to immunoprecipitation (IP) (see Fig. 3C). IPs were performed over-
night in 0.1% Nonidet P-40 (NP-40)–PBS, after which the beads were washed
five times with buffer (10 mM Tris-HCl [pH 8.0], 0.1% NP-40, 150 mM NaCl).
Proteins were eluted by adding 20 l of SDS-PAGE loading buffer supplemented
with 4 l of nuclear extract as a carrier and incubating at 95°C for 10 min. IP of
U11/U12 snRNPs from nuclear extracts with SF3b155 antibodies was performed
essentially as described previously (39).
Far-Western overlays. Coupled transcription and translation of the 48K pro-
tein and mutant forms thereof and a 59K mutant protein comprising amino acids
137 to 336 (59K137–336) were performed using the TNT system (Promega) in the
presence of [35S]methionine or [14C]leucine, or alternatively, in vitro-transcribed
mRNA was isolated and translated in wheat germ extract (Zoegene, Japan)
essentially as described in reference 29. Far-Western overlay analyses were
performed with 35S-labeled protein, and purified U11/U12 proteins were immo-
bilized on nitrocellulose as described previously (1).
Yeast two-hybrid assays. Yeast two-hybrid analyses were performed with the
Matchmaker 3 two-hybrid system (Clontech). cDNAs encoding full-length or
truncated proteins were cloned into pGBKT7 (the bait vector) or pGADT7 (the
prey vector). S. cerevisiae strain AH109 was cotransformed with bait and prey
plasmids, and the plasmids were selected on agarose plates prepared with min-
imal synthetic dropout medium lacking leucine and tryptophan by incubation at
30°C for 3 to 5 days. To identify protein-protein interactions, cotransformants
were then replicated on plates additionally lacking histidine and adenine (plates
containing synthetic dropout medium without Ade, His, Leu, or Trp).
StrepII tag pulldown assays. For pulldown assays, cDNA encoding 59K137–336
was cloned into pEU3-NII-StrepII via PCR-based techniques and 59K137–336
containing a C-terminal StrepII tag was translated in wheat germ extract. Forty
microliters of the translated 59K137–336 was incubated with 40 l of translated
48K for 90 min at 0°C, prior to the addition of 15 l of Strep-Tactin Sepharose
(IBA, Go¨ttingen, Germany) and 200 l of IPP150 buffer (20 mM HEPES-KOH,
pH 7.9, 150 mM NaCl, 1.5 mM MgCl2, 0.05% NP-40). The mixture was incu-
bated with end-over-end rotation for 1 h, and after the beads were washed four
times with IPP150 buffer, bound protein was recovered and analyzed by SDS-
PAGE.
Cell culture, RNAi, and qRT-PCR analysis of siRNA-targeted mRNAs. Cul-
turing of HeLa S6 cells and the transfection of cells with siRNA duplexes by
using Oligofectamine (Invitrogen) were performed essentially as described in
reference 38. The targeted regions were not found in any other known genes via
BLAST searches of the human genome. To assay for effects on cell growth, HeLa
cells were harvested 24, 48, 72, and 96 h after transfection with siRNA and
counted with a CASY model TT cell counter according to the instructions of the
manufacturer (Schaerfe System, Germany). For 48K rescue experiments, the
48K cDNA with four mutations (silent on the amino acid level) in the region
bound by the 139-1 siRNA was cloned into the pcDNA4 expression vector
(Invitrogen), generating pcDNA-48K. Twelve hours after siRNA addition, cells
were transfected with pcDNA-48K (75 ng per 2.25  105 cells) by using Trans-
fectin lipid reagent according to the instructions of the manufacturer (Bio-Rad).
Total cellular RNA was isolated using an RNeasy mini kit (Qiagen) and digested
with RQ1 DNase (Promega) to remove any contaminating DNA. The level of
48K mRNA remaining after transfection with siRNA BB1 versus siRNA 139-1
was determined by qRT-PCR with an Opticon continuous-fluorescence detector
(MJ Research). As an internal control, the level of mRNA encoding glutamate
dehydrogenase 2 (which is not spliced) was also determined by qRT-PCR. Small-
scale nuclear extracts were prepared essentially as described in reference 19.
Nuclear extracts were fractionated on 10 to 30% glycerol gradients, and snRNAs
were detected by Northern blotting as described previously (38).
RT-PCR analysis of endogenous pre-mRNA in 48K knockdown cells. The
removal of U12- and U2-type introns from pre-mRNA was analyzed by RT-PCR
with total cellular RNA from control and 48K knockdown cells after 72 h.
First-strand cDNA was synthesized using SuperScript III reverse transcriptase
(Invitrogen) with oligo(dT) primers, followed by 26 cycles (32 cycles with RCD8
and PPP2R2A primers) of amplification using Phusion DNA polymerase
(Finnzymes). For details of the analyzed introns and the primers used, see Table
S1 in the supplemental material. The RT-PCR products were separated on 2.5 to
3.0% Metaphor agarose (Cambrex) gels.
RESULTS
The mutation of the conserved 3 position of U12-type
introns blocks prespliceosome assembly. The RUA motif at
the 5ss of U12-type introns is nearly 100% conserved (31)
(Fig. 1A), and the identities of the first two nucleotides of this
motif are critical for splicing in vivo (2). Here, we initially
tested whether mutations at the3 position affect spliceosome
assembly and/or the splicing of a pre-mRNA substrate (the
P120 substrate) containing a U12-type intron. The P120 sub-
strate with a U2C mutation was used as a positive control.
The WT P120 substrate was spliced in vitro, as indicated by the
accumulation of excised intron products (Fig. 2A, lanes 2 and
3), and formed a stable A complex (Fig. 2B, lane 2) whose
formation could be blocked by the addition of an anti-U12
oligonucleotide (Fig. 2B, lane 3). In contrast, no splicing or A
complex formation was observed when A3 was mutated to C,
G, or U (Fig. 2A and B). Thus, the identity of the third intron
nucleotide is also critical for splicing.
In subsequent studies, we used the A3G substrate, in
which a conservative purine-to-purine change was made. For
comparison, we also tested P120 pre-mRNA with a CC56
GG mutation, which has been shown to block U12-dependent
FIG. 2. 5ss mutations block spliceosome assembly. (A) In vitro splicing of 32P-labeled P120 splicing substrates. Substrates, incubation times,
and the presence or absence of anti-U12 2ome oligonucleotide used to block A complex formation are indicated at the top. After splicing, RNA
was separated on a 7.5 M urea–5% acrylamide gel and visualized by autoradiography. DNA molecular weight markers (m) are indicated on the
left, and the positions of pre-mRNAs (bars and line), ligated exons (bars), and the excised intron (lariat) are indicated on the right. Asterisks
indicate unspecific products. t, time; , present; , absent. (B) Splicing complex formation with P120 splicing substrates. For the top panel,
complexes with 32P-labeled pre-mRNA were separated by nondenaturing PAGE and visualized by autoradiography. For the remaining panels,
complexes with unlabeled pre-mRNA were separated by nondenaturing PAGE and visualized by Northern blotting with the 32P-labeled probes
indicated on the left. The positions of the U11/U12 di-snRNP and A and H complexes are indicated. (C) In vitro splicing of 32P-labeled WT,
A3G, and CC56GG P120 pre-mRNAs. Splicing was analyzed as described in the legend to panel A, and symbols are as defined in the legend
to panel A. (D) Splicing complex formation with 32P-labeled WT, A3G, and CC56GG P120 pre-mRNAs. Complexes were separated by
nondenaturing PAGE and visualized by autoradiography. “5ss oligo” indicates a DNA oligonucleotide complementary to the 5ss, used to induce
the hydrolysis of pre-mRNA by endogenous RNase H. H, A, and B complexes are indicated on the left. (E) Splicing complex formation with WT
and mutant P120 substrates as assayed by RNase H protection assays. A DNA oligonucleotide complementary to the 5ss was used to induce
site-specific cleavage by RNase H (lanes 1, 5, and 9). Background protection of the 5ss was monitored either by blocking the A complex as
described in the legend to panel A (lanes 2, 6, and 10) or by preannealing the DNA oligonucleotide to the substrate prior to A complex assembly
(lanes 3, 7, and 11). An intron-specific DNA oligonucleotide was used to determine the general background level of protection (lanes 4, 8, and
12). RNA was subsequently separated on a 7.5 M urea–6% acrylamide gel. The positions of the protected P120 substrates and their hydrolysis
products are indicated on the right, and the positions of molecular weight markers are shown on the left. (F) Quantitation of 5ss protection. The
amount of protected pre-mRNA is expressed as the percentage of the total pre-mRNA in each lane of the gel in panel E. The mean values obtained
from three independent experiments are shown, with error bars indicating the standard deviations. Column pairs with paired-t-test P values below
0.05 are indicated by asterisks. Columns correspond to the identically numbered lanes in panel E.
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splicing in vivo due to the disruption of the base pairing of both
U11 and U6atac snRNAs (14). Like the A3G substrate, the
CC56GG substrate was not spliced and did not form stable
spliceosomal complexes (Fig. 2C and D). RNase H protection
assays that allow the detection of less stable U11-5ss interac-
tions (10) confirmed that splicing complex formation with the
A3G and CC56GG substrates was essentially abolished;
no protection of the 5ss (as indicated by the lack of protection
values significantly over background protection values) was
observed (Fig. 2E and F). In contrast, ca. 4% of the WT
substrate (i.e., ca. 10-fold more than the background level) was
protected (Fig. 2F), similar to previously published observa-
tions (10). Thus, mutations in the RUA motif block spliceo-
some assembly at a very early stage, suggesting that the motif
is recognized in a sequence-specific manner by a functionally
important component during prespliceosome assembly.
FIG. 3. The U11-48K protein interacts with the 2 position of U12-type introns. (A) Schematic representation of the cross-linking substrates
used in this study. 4SU is indicated by a circled U, and the position of the 32P-labeled phosphate group is indicated by a black dot. Underlining
indicates mutated nucleotides. BP, branch point; WT2, substrate with 4SU at the 2 position; BPS, substrate truncated directly upstream of
the BPS. (B) Cross-linking was performed after 40 min of splicing with the P120 substrate indicated above each lane. Cross-linked proteins were
separated by SDS-PAGE and visualized by autoradiography. Molecular size markers are indicated on the left. The 45-kDa cross-linked protein is
indicated by an arrow. (C) Identification of the cross-linked 45-kDa protein. Cross-linking was performed with the WT2 P120 substrate. Samples
were immunoprecipitated with the indicated antibody either directly () or after RNase digestion and denaturing with SDS () and were analyzed
as described in the legend to panel B. (D to G) Effect of ATP depletion (D) or Mg2 depletion (E) on 48K-5ss cross-link formation. Reactions
were performed with () or without () exogenously added ATP or Mg2. For panels D to G, cross-linking was performed with the WT2 P120
substrate and samples were denatured and immunoprecipitated with anti-48K antibody. (F) Time course of 48K-5ss cross-link formation. Samples
were removed from the reaction mixture at the indicated times after the start of splicing and placed on ice prior to cross-linking. (G) Effects of
anti-snRNA 2ome oligonucleotides on 48K cross-link formation. Splicing was performed in the presence of a 2ome oligonucleotide against the
indicated snRNA. For lane 4, UV irradiation was omitted. (H) Cross-linking was performed after 40 min of splicing with the P120 substrate
indicated above each lane. Cross-linked proteins immunoprecipitated with anti-48K antibody (	-48K) were separated by SDS-PAGE (lanes 6 to
10) along with 25% of the input (lanes 1 to 5). Molecular weight markers are shown on the left. The 48K band is indicated by an arrow.
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The U11/U12 48K protein makes contact with the 5ss dur-
ing prespliceosome assembly. To detect proteins interacting
with the RUA motif, we performed site-specific cross-linking
with WT, A3G, and CC56GG P120 pre-mRNAs, in
which a 4SU residue and a single 32P-labeled phosphate group
were placed at the 2 position relative to the 5ss. Control
substrates with 4SU at the 2 position, without 4SU, or with a
3 truncation were also analyzed (Fig. 3A). Splicing and splic-
ing complex formation were not significantly hindered by in-
troducing 4SU at positions2 and2 (9, 10) (data not shown).
Splicing was performed with HeLa nuclear extracts, and
cross-linking was induced by UV irradiation. RNA was then
degraded enzymatically, and cross-linked proteins were sepa-
rated by SDS-PAGE and visualized by autoradiography. Four
bands (corresponding to 
35, 45, 100, and 220 kDa) were
reproducibly observed after 40 min of splicing with the P120
substrate containing 4SU at the 2 position (WT2) (Fig. 3B,
lane 1) but not with the substrate lacking 4SU (the WT) (Fig.
3B, lane 2). Of these bands, only the 45-kDa cross-link band
was not observed with either the CC56GG substrate or the
substrate with 4SU at the 2 position (Fig. 3B, cf. lanes 3 and
4 with lane 1), indicating that the 45-kDa cross-linked protein
interacts specifically with the 2 position in a manner depen-
dent on either U11 or U6atac base pairing with the 5ss. In the
absence of SDS, the cross-linked 45-kDa protein was precipi-
tated to various degrees by antibodies against the U11/U12
35K, 48K, and 65K proteins and the SF3b49 protein (Fig. 3C),
suggesting that it is a U11/U12 protein. In contrast, after de-
naturation with SDS, which disrupts all protein-protein and
protein-RNA interactions, it was precipitated solely by the 48K
antibody (Fig. 3C, lane 6), identifying it as the U11/U12 48K
protein.
Similar to that of U11-5ss cross-linking (42), the efficiency
of 48K-5ss cross-linking was not significantly affected when
the splicing reaction mixture was depleted of ATP (Fig. 3D) or
Mg2 (Fig. 3E). However, unlike U11 (8, 42), 48K was not
efficiently cross-linked at 0°C (Fig. 3F, lane 1). The 48K cross-
linked protein was present in equal amounts after incubation
at 30°C for 10 and 20 min (when only the A complex forms),
but the amount started to decline by 40 min (when the B
complex appears) (10) (Fig. 3F, lanes 2 to 4), suggesting that
48K interacts early during spliceosome assembly in a transient
manner. Indeed, blocking the U6atac-5ss interaction with a
2ome oligonucleotide against U6atac had no effect on 48K-5ss
cross-link formation, suggesting that 48K interacts prior to B
complex formation (Fig. 3G). Blocking U12-BPS base pairing
with a 2ome oligonucleotide against U12 (Fig. 3G) or truncat-
ing the splicing substrate directly upstream of the BPS (Fig.
3H, lane 9) led to a 3- to 4-fold or 
2-fold reduction in
cross-linking efficiency, respectively. Thus, the 48K-5ss inter-
action is not dependent on BPS recognition but may be en-
hanced by the cooperative recognition of the U12-type 5ss and
the BPS (10). We conclude that 48K makes contact with the
5ss during the early stages of intron recognition, apparently
prior to BPS and 5ss recognition by the U12 and U6atac
snRNAs, respectively.
Strikingly, the A3G mutation almost completely abolished
cross-linking of the 48K protein (yielding a 30- to 60-fold
reduction relative to the level observed with the WT2 con-
struct) (Fig. 3H, lane 7). As this mutation was also shown to
inhibit prespliceosome formation (Fig. 2F), the loss of the 48K
cross-linked protein correlated with impaired 5ss recognition,
suggesting that the cross-link is not lost due to merely a change
in the local orientations of the RNA and the cross-linker.
These data suggest that 48K interacts in a sequence-specific
manner with the RUA motif either directly or indirectly via an
unknown partner that specifically recognizes this motif (see
Discussion).
The 48K-5ss interaction is generally found in U12-depen-
dent spliceosomes. To address the generality of the 48K-5ss
interaction, we constructed a second set of splicing substrates
containing a U12-type intron of the GT-AG subtype, derived
from the ninth intron of the mouse Vps16 gene. Like the P120
substrates (Fig. 2C and D), the uniformly labeled Vps16 WT
substrate was assembled into spliceosomal complexes and was
spliced while the A3G and CC56GG mutant forms were
not (data not shown). The efficiency of cross-link formation
with the Vps16 substrate was somewhat higher than that with
the P120 substrate, resulting in more background bands (Fig.
4). IP with anti-48K antibody revealed that 48K is efficiently
cross-linked to the Vps16 WT2 substrate (Fig. 4, lane 5). In
contrast, a large reduction (ca. 50- and 10-fold) in 48K cross-
linking was observed with the A3G and CC56GG mutant
substrates, respectively (Fig. 4). Thus, 48K makes contact with
the 5ss of both AT-AC and GT-AG U12-type introns.
RNAi reveals an essential cellular function for the 48K
protein. To investigate whether the 48K protein carries out an
essential function in vivo, we performed RNAi-mediated 48K
knockdowns. We transfected HeLa cells with four different
siRNA duplexes against 48K. Three led to either no or solely
a moderate reduction in the level of 48K mRNA and corre-
spondingly had no effect on cell growth (data not shown). With
a fourth siRNA (139-1), cell growth was inhibited by 70%
relative to that corresponding to the control siRNA BB1 (di-
rected against fly luciferase) after 96 h (Fig. 5A). By compar-
ison, the knockdown of the essential spliceosomal protein
hPrp8 led to 90% growth inhibition. Due to the low cellular
abundance of U11/U12 proteins and the relatively weak anti-
bodies at our disposal, it was not possible to determine the
FIG. 4. 48K is cross-linked to the GU-AG U12-type intron of the
Vps16 pre-mRNA. 48K cross-link formation with the Vps16 WT2
and 5ss mutant substrates was analyzed as described in the legend to
Fig. 3H. 	-48K, anti-48K antibody.
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amount of 48K protein in the control versus that in knockdown
cells. However, qRT-PCR confirmed that only 
10 to 15% of
the 48K mRNA was present in cells transfected with siRNA
139-1 already after 24 h and at later time points but that the
levels of mRNAs encoding other U11 proteins (e.g., 35K and
25K) were not affected by the addition of 139-1 siRNA (data
not shown). These results indicate that 48K plays an essential
role in the cell, consistent with the idea that it functions in
U12-independent splicing.
RNAi knockdown of 48K leads to the activation of cryptic
splice sites. To ascertain whether the observed reduction in
cell viability was due to a defect in U12-dependent splicing, we
performed RT-PCR with endogenous RNA isolated from cells
72 h after the addition of siRNA. The seven U12-type intron-
containing transcripts studied here were recently described by
Sheth et al. (31). We observed a modest reduction in the
splicing of the U12-type introns of Mapk12 and Vps16 pre-
mRNAs in the 48K knockdown cells, as evidenced by an in-
crease in unspliced pre-mRNA and a corresponding reduction
in mRNA (Fig. 5B and C). In contrast, splicing of U2-type
introns of the same pre-mRNAs or of the beta-actin and glyc-
eraldehyde-3-phosphate dehydrogenase (GADPH) pre-
mRNAs, which lack U12-type introns, was not affected (Fig.
5C). However, the splicing efficiencies for some of the U12-
type introns assayed were not significantly affected by 48K
knockdown (a maximum difference of twofold in Drap1,
Pex16, and Psmc4 pre-mRNA levels was detected) (Fig. 5C),
presumably due to the residual amount of 48K present in the
cells (see above), which for some U12-type introns may still be
sufficient for splicing.
To exclude the possibility that the observed inhibition of
U12-type splicing was due to off-target effects of the 48K 139-1
siRNA, cells were transfected 12 h after siRNA addition with
a plasmid containing the 48K cDNA with silent point muta-
tions in the region targeted by 139-1 (designated pcDNA-48K).
The level of 48K mRNA (72 h after transfection with siRNA)
increased in the 48K knockdown cells from 12% in the absence
of pcDNA-48K to 41% in its presence, demonstrating the
partial rescue of 48K levels (Fig. 5E). Significantly, the splicing
of the U12-type introns Mapk12-8, Vps16-9, and Vps16-13 was
partially restored upon the addition of pcDNA-48K, as evi-
denced by the significant decrease in the levels of pre-mRNAs
containing these introns in 48K knockdown cells that received
the plasmid compared to those in cells that did not (Fig. 5E).
In contrast, U12-type splicing in BB1 control knockdown cells
was not affected by the addition of pcDNA-48K (Fig. 5E).
Taken together, these data demonstrate that 48K knockdown
leads to a reduction in the splicing of at least a subset of
U12-type introns.
For Mapk12, a faster-migrating band not present in the
control reaction mixture was detected in the knockdown cells
(Fig. 5B, lane 1). Sequence analysis of this band revealed that
it arose by the activation of a cryptic, U2-type 5ss (Fig. 5D).
The activation of cryptic splice sites after 72 h of 48K knock-
down was also observed with two other transcripts, namely,
those for PPP2R2A and RCD8 (Fig. 5D), neither of which
displayed a significant accumulation of pre-mRNA after 48K
knockdown. RCD8 transcripts displayed the highest level of
cryptic splicing, with 
30% of the mRNA in the knockdown
cells spliced at cryptic sites (data not shown).
Interestingly, the 5ss and BPS of the U12-type introns that
were most sensitive to 48K knockdown exhibited a number of
deviations from the respective U12-type consensus sequences,
suggesting that they may be weak sites, while those not affected
by 48K knockdown had 5ss and BPS closely matching the
consensus sequences (Fig. 5F). The switch from U12- to U2-
dependent splicing does not appear to be an alternative splic-
ing event, as expressed-sequence-tag (EST) database searches
revealed no Mapk12, PPP2R2A, or RCD8 ESTs generated
from splicing at the observed U2-type splice sites. Thus, 48K
plays a critical role in the recognition of U12-type introns in
vivo.
The knockdown of 48K leads to a reduction in U11/U12
di-snRNP levels. To test whether 48K contributes to di-snRNP
stability and formation, we prepared nuclear extracts from
control or 48K knockdown cells. Extracts were then subjected
to glycerol gradient centrifugation, and after fractionation, the
sedimentation behavior of snRNPs containing U11 or U12 was
FIG. 5. 48K knockdown affects cell growth and U12-dependent splicing. (A) 48K knockdown inhibits cell growth. Cell growth, expressed
as the percentages of cells present relative to the numbers of cells in the control siRNA BB1 knockdown culture, was determined 24, 48,
72, and 96 h after the transfection of cells with an siRNA duplex against the 48K protein or, as a positive control, against hPrp8. Values are
the averages of triple determinations. (B and C) The splicing of a subset of U12-type pre-mRNAs is reduced after 48K knockdown. RNA
from either 48K knockdown (KD) or control (C) cells was used for RT-PCR amplification across U12- or U2-type introns of the indicated
transcripts. In panel B, the RT-PCR products of Mapk12 and Vps16 pre-mRNAs containing U12-type introns and spliced mRNA are
indicated by closed and open arrows, respectively, and the cryptically spliced product is indicated by an asterisk. Intron numbers are indicated
in parentheses. (C) The amount of pre-mRNA as a percentage of the total pre-mRNA and mRNA for all introns studied is shown. Mean
values obtained from six (Mapk12 and Vps16 transcripts) or four experiments are shown, with error bars indicating standard deviations.
Column pairs with paired-t-test P values below 0.01 are marked with asterisks. ACTB, beta-actin transcripts. (D) 48K knockdown leads to
the activation of cryptic splice sites. The RT-PCR products of mRNA spliced by the U12- or U2-type spliceosomes are indicated on the left.
Splice site usage is shown schematically on the right, with the intron lengths indicated in parentheses. The normal U12-type splice sites are
indicated above, while the cryptic U2-type splice sites activated in the knockdown cells are indicated below. (E) The inhibition of U12-type
splicing is partially reversed by transfection with the plasmid encoding 48K. The rescue plasmid (pcDNA-48K) was added 12 h after
transfection with BB1 or 139-1 siRNA, as indicated, and RNA was isolated 72 h posttransfection with siRNA. The level of unspliced
pre-mRNA was determined as described in the legend to panel C, and the averages from triplicate RT-PCRs are shown. The presence ()
or absence () of the rescue plasmid is indicated below the graph, and the level of 48K mRNA in each case is shown in the insert.
(F) Comparison of the 5ss and BPS of U12-type introns investigated by RT-PCR. The human consensus (cons.) sequences are shown at the
top. The intron number is in parentheses. Deviations from the consensus are indicated by lowercase letters, and deletions are indicated by
hyphens. The introns are divided into three groups according to the severity of the 48K knockdown effect, as follows: group 1, little or no
effect; group 2, reduced U12-dependent splicing; group 3, activation of cryptic splice sites.
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determined by Northern blot analysis with the corresponding
32P-labeled probe; as an internal control, the distribution of U2
snRNPs was also analyzed (Fig. 6A to D). No significant dif-
ference in the sedimentation behavior of U2-containing
snRNPs (i.e., 17S and 12S particles) was observed in extracts
from the control versus the 48K knockdown cells (Fig. 6C and
D). In contrast, upon 48K knockdown, a smaller percentage of
the total U11 snRNA present sedimented in 18S peak fractions
9 to 10 (20 versus 39% in the control as determined by phos-
phorimager analysis) and a larger percentage sedimented in
12S peak fractions 4 to 5 (27 versus 14% in the control) (Fig.
6A and B), suggesting that the knockdown cells contained

50% less U11/U12 di-snRNP than the control cells. Likewise,
more U12 sedimented as a 15S monoparticle in the 48K knock-
down cells; however, due to the close migration of 15S and 18S
particles, a meaningful quantitation of U12 mono-snRNPs ver-
sus di-snRNPs could not be carried out. To provide additional
evidence for a reduction in di-snRNP levels after 48K knock-
down, we also performed co-IP assays with antibodies directed
against the U12-associated SF3b155 protein. Significantly, on
average only half as much (50%  7%) of the input U11 was
precipitated together with U12 by anti-SF3b155 antibodies
from the 48K knockdown extracts as from the control extracts
(Fig. 6E, cf. lanes 3 and 4 with lanes 7 and 8), consistent with
the conclusion that 48K knockdown cells contain 
50% fewer
U11/U12 di-snRNPs than control cells. Thus, 48K appears to
contribute to the formation and/or the stability of the U11/U12
di-snRNP.
The N terminus of 48K interacts with the central region of
U11-59K. To identify protein interaction partners of the 48K
protein within the U11/U12 di-snRNP, we first performed two-
hybrid interaction assays with the yeast S. cerevisiae. When 48K
was used as bait, it interacted strongly with U11-59K but not
with any of the other U11/U12-specific proteins tested (Fig.
7B, left panel). As the 48K cDNA could not be cloned into the
pGBKT7 vector, reciprocal two-hybrid screens with 48K as
prey could not be performed. To further delineate the 48K-
59K interaction, 59K was divided into its N-terminal proline-
rich region (59K1–135), its arginine-rich region (59K137–336),
and its C-terminal region rich in glutamic acid (59K332–485)
(Fig. 7A). When these 59K deletion mutant proteins were used
as prey, only 59K137–336 interacted with 48K (Fig. 7B, right
panel). Significantly, no interaction between 59K137–336 and
the U11/U12-specific 65K, 35K, 25K, or 20K protein used as
either bait or prey was observed (data not shown). These
results indicate that 48K interacts specifically with amino acids
137 to 336 of the 59K protein. Attempts to express full-length
48K as a fusion protein in Escherichia coli were not successful,
apparently due to the arginine-rich C terminus of 48K. To
provide additional evidence that 48K interacts with 59K, we
performed far-Western overlay analyses with in vitro-trans-
lated, 35S-labeled 48K or 59K137–336 protein and nitrocellulose
strips containing U11/U12 proteins. Consistent with the yeast
two-hybrid results, 35S-labeled 48K interacted predominantly
with 59K and 35S-labeled 59K137–336 interacted predominantly
with 48K (Fig. 7C, lanes 2 and 3). The 48K-59K interaction
appears to be specific, as other proteins that were equally
abundant (as evidenced by Ponceau staining) (Fig. 7C, lane 1)
were not efficiently bound by the 35S-labeled proteins.
To further delineate which region of 48K interacts with 59K,
several 48K deletion mutant proteins were constructed (Fig.
7A), translated in vitro, and first tested in Far Western overlays
with nitrocellulose strips containing U11/U12 proteins. Full-
length 35S-labeled 48K, as well as all deletion mutant proteins
containing the 92 N-terminal amino acids (i.e., 48KArg,
48K1–199, and 48K1–92), interacted strongly with 59K (Fig. 7D,
lanes 2 to 5). In the absence of amino acids 1 to 92, no
interaction was detected (Fig. 7D, lanes 6 and 7), indicating
that the N terminus of 48K is necessary and sufficient for
interaction with 59K. Interestingly, this region of 48K contains
a potential CHHC zinc finger motif, which is highly conserved
evolutionarily (see Fig. S1 in the supplemental material). To
confirm this interaction, 59K137–336 containing a StrepII tag
was translated in vitro and incubated with in vitro-translated
14C-labeled 48K and deletion mutant forms thereof. 59K was
then precipitated with Strep-Tactin Sepharose beads, and co-
precipitating proteins were analyzed by SDS-PAGE, followed
by autoradiography. Consistent with the Far Western results,
all 48K mutant proteins containing amino acids 1 to 92 bound
to 59K137–336 with efficiencies nearly identical to that of the
FIG. 6. 48K knockdown leads to a reduction in U11/U12 di-
snRNPs. (A to D) Fewer U11 and U12 snRNPs sediment as an 18S
di-snRNP upon the knockdown of 48K. Nuclear extracts isolated from
cells treated with BB1 (A and C) or 139-1 (B and D) siRNA for 72 h
were separated on a 10 to 30% glycerol gradient. RNA was recovered
from the indicated gradient fraction, and Northern blotting was per-
formed with 32P-labeled probes against U11 and U12 snRNAs (A and
B) or subsequently with a probe against U2 (C and D). (E) Less U11
is coprecipitated with U12 snRNPs from 48K knockdown (48K KD)
extracts than from control knockdown (control KD) extracts. IPs were
performed with SF3b155 antibody (	-SF3b155) and nuclear extracts
from BB1- or 139-1-treated cells, as indicated. RNA was recovered and
analyzed by Northern blotting with probes against U11 and U12. In
lanes 4 and 8, 20% less extract was analyzed.
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FIG. 7. The N terminus of the U11-48K protein interacts with the central region of the U11 59K protein. (A) Schematic of WT and truncated 48K
and 59K proteins. Arginine (Arg)-, proline (Pro)-, and glutamic acid (Glu)-rich regions and a potential zinc finger (ZnF?) are shaded gray. (B) Results
from yeast two-hybrid assays with the 48K protein and the U11/U12-associated 20K, 25K, 35K, 59K, and 65K proteins and deletion mutant forms of 59K,
as indicated. SD:-A-H-L-T, synthetic dropout medium without Ade, His, Leu, or Trp. (C) 48K and 59K interact in far-Western overlays. U11/U12
proteins on nitrocellulose strips were visualized by staining with Ponceau S (lane 1) or incubated with 35S-labeled, in vitro-translated 48K protein
or 59K137–336 and visualized by fluorography (lanes 2 and 3). U11/U12 proteins are indicated on the left. (D) The N-terminal region of 48K interacts with
59K in Far Western overlays. Overlay analyses were performed as described in the legend to panel C. (E) The N-terminal region of 48K interacts with
59K137–336.
14C-labeled 48K and deletion mutant forms thereof were incubated alone (lanes 2, 5, 8, 11, 14, 17, and 20) or with StrepII-tagged 59K137–336
(lanes 3, 6, 9, 12, 15, 18, and 21), and pulldowns were subsequently performed with Strep-Tactin Sepharose beads. Coprecipitated 48K protein or 10%
of the input (lanes 1, 4, 7, 10, 13, 16, and 19) was analyzed by SDS-PAGE and visualized by fluorography. DHFR, dihydrofolate reductase.
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WT 48K protein (
10%), whereas mutant proteins lacking this
region did not (Fig. 7E). These results indicate that 48K not
only makes contact with the 5ss of U12-type introns but also
interacts with the U11-59K protein and, thus, may possess dual
binding affinities.
DISCUSSION
In this study, we detected a novel interaction between the
U11-48K protein and the 5ss of U12-type introns and pro-
vided evidence suggesting that this interaction is required for
proper intron recognition. In addition, we demonstrated that
48K interacts with the U11-59K protein, a protein at the in-
terface of the U11/U12 di-snRNP, and provided evidence that
48K contributes to di-snRNP formation and/or stability. Taken
together, our data provide important insights into the protein-
mediated recognition of the U12-type 5ss, as well as function-
ally important interactions within the U11/U12 di-snRNP.
48K makes contact with the 5ss in early spliceosomal com-
plexes. We detected an interaction between 48K and the 5ss
(Fig. 3 and 4), consistent with the idea that 48K participates in
U12-type 5ss recognition and that 48K knockdown leads to
impaired U12-dependent splicing by preventing this interac-
tion. Furthermore, several lines of evidence support the idea
that the 48K-5ss interaction takes place early during intron
recognition. First, 48K could be cross-linked soon after the
start of splicing in vitro (Fig. 3F) and seemed to require the
U11-5ss base pairing interaction (see below). Second, 48K-
5ss cross-link formation did not require U6atac-5ss or U12-
BPS base pairing (Fig. 3G) or the presence of the BPS (Fig.
3H), suggesting that the 48K-5ss interaction precedes U12-
BPS base pairing. Finally, 48K knockdown led to the activation
of cryptic, U2-type splice sites (Fig. 5D). As commitment to
either U2- or U12-type splicing is thought to occur at the time
of A complex formation (for a discussion, see reference 14),
48K must act during or prior to this step. 48K is associated with
the U11 moiety of the U11/U12 di-snRNP, and thus, it likely is
displaced from the 5ss at a later stage of spliceosome assem-
bly, when the U11 snRNP is thought to dissociate. Indeed, 48K
cross-linking was reduced after 40 min of splicing (Fig. 3F),
which correlates with reduced U11-5ss cross-link formation
(8). However, at present, we cannot exclude the possibility that
48K remains bound to the 5ss at later stages of spliceosome
assembly.
The 48K-5ss interaction appears to be greatly enhanced by
U11-5ss base pairing. The CC56GG mutation, which abol-
ishes U11-5ss base pairing (14), greatly diminished 48K-5ss
cross-link formation (Fig. 3H and Fig. 4). Theoretically, this
mutation could also hinder protein interactions with nt 5
and/or 6. However, as the splicing defect caused by the CC
56GG mutation could be eliminated by compensatory muta-
tions in U11 and U6atac snRNAs in vivo (14), it appears that
there are no critical RNA-protein interactions with these nu-
cleotides. In summary, 48K interacts with the 5ss during the
very first steps of intron recognition, apparently together with
or after U11 snRNA.
48K may recognize the 5ss in a sequence-specific manner.
The mutation of the conserved RUA motif (A3G), which
prevents base pairing with the U11 snRNA, abolished both the
stable interaction of U11 snRNP with the 5ss (Fig. 2) and the
48K cross-link (Fig. 3 and 4). This finding suggests indirectly
that 48K recognizes the 5ss in a sequence-specific manner
and, further, that the 48K-5ss interaction helps to stabilize the
U11-5ss interaction. In the major spliceosome, the 5ss is
recognized by the U1-C protein, which can bind the 5ss on its
own and subsequently promotes the U1-5ss interaction (4, 5,
27). It is not clear whether 48K and U1-C act in mechanistically
similar manners. However, the different compositions of U1
and U11 proteins hint at mechanistic differences. Furthermore,
in contrast to the U1-C-5ss interaction, data presented here
suggest that the 48K-5ss interaction occurs either concomi-
tantly with or after U11-5ss base pairing.
Whether 48K can bind the U12-type 5ss on its own is cur-
rently also unknown; due to the inability to overexpress the
WT 48K protein in E. coli, RNA binding studies with purified
48K could not be performed. Recently, serine-arginine-rich
(SR) proteins were shown to interact with a U12-type 5ss (30),
and they may possibly mediate the 48K-5ss interaction either
directly or indirectly by modulating U11-5ss base pairing.
Other U11/U12 proteins not found in the major spliceosome
may also contribute to 5ss recognition. Most notably, the
U11/U12-20K protein shows some similarity to U1-C, includ-
ing an N-terminal zinc finger, and it was thus proposed that the
20K protein may be involved in U12-type 5ss recognition (38).
However, 20K was not copurified with U11 monoparticles.
Furthermore, we did not detect a 20K-5ss interaction via
cross-linking, at least at the 2 or  2 position (data not
shown). Thus, additional experiments are required to clarify
whether proteins in addition to 48K uniquely contribute to 5ss
recognition in the minor spliceosome.
48K plays a critical role in the recognition of U12-type
introns. RNAi-induced knockdown of 48K leads to reduced
cell growth, indicating that 48K has an essential cellular func-
tion (Fig. 5A). This function appears to be related to the
recognition of U12-type introns, as 48K knockdown leads to
reduced U12-dependent splicing and/or the activation of cryp-
tic splice sites in certain pre-mRNAs containing U12-type in-
trons (Fig. 5). These effects may be due partially to the reduc-
tion of U11/U12 di-snRNP levels in 48K knockdown cells (Fig.
6). However, as snRNPs are present in large excess in the cell,
it is unlikely that a 50% reduction in di-snRNP levels alone
would cause the observed effects. Indeed, residual amounts
(20%) of U4atac snRNA are sufficient to support the splicing
of endogenous pre-mRNAs at WT levels (25), suggesting that
the reduction of a single spliceosomal component by 80 to 90%
does not a priori lead to splicing inhibition.
The removal of some U12-type introns was not significantly
affected by 48K knockdown. As residual amounts of 48K
mRNA remain after knockdown, some introns appear to be
more sensitive to 48K levels than others. Interestingly, 48K
knockdown had little or no effect on the removal of introns in
which both the 5ss and BPS matched the consensus se-
quences, whereas introns with deviations in their 5ss or BPS
were removed less efficiently or no longer recognized as U12-
type introns after knockdown. It is likely that the formation
and/or stability of the minor prespliceosome is dependent on
the combined effects of several sequence-specific interactions
at the 5ss and BPS, including U11-5ss base pairing, 48K-5ss
interaction, and U12-BPS base pairing, possibly augmented by
SR proteins that recognize nearby regulatory elements (13,
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30). Thus, 48K knockdown may lead to the defective formation
of prespliceosomes solely on introns with suboptimal recogni-
tion sequences, especially in the absence of splicing enhancers.
Protein-protein interactions within the U11/U12 di-snRNP.
Our knockdown data indicated that 48K contributes to the
stability of the U11/U12 di-snRNP (Fig. 6). Interestingly, di-
rect interactions between 48K and integral components of U12
(e.g., SF3b or the 65K and 20K proteins) were not detected,
suggesting that 48K may not be located at the interface be-
tween the U11 and U12 moieties of the di-snRNP. However,
protein-protein interaction studies (Fig. 7) demonstrated that
48K interacts with another U11-associated protein, namely,
59K, and that this interaction involves the central arginine-rich
region of 59K and the N-terminal region of 48K. The latter
contains a putative zinc finger, a motif shown in several cases
to mediate protein-protein interactions (11). Significantly, the
C-terminal part of 59K interacts with the U12-65K protein,
and thus, both of these proteins lie at the interface of the
di-snRNP and likely play an important role in di-snRNP for-
mation and stability (1). Thus, it is conceivable that 48K, via its
interaction with 59K, may indirectly affect the association of
the U11 and U12 snRNPs in the U11/U12 di-snRNP.
Our studies further suggest that 48K possesses dual binding
activities, interacting not only with 59K but also with the 5ss.
At present, the regions of 48K responsible for RNA interac-
tions are not known, as the inability to express WT 48K in
significant amounts in E. coli has hampered studies to examine
this issue. The sequence of 48K also offers few clues as to which
amino acids may be involved in RNA binding, as it contains no
known motifs apart from a putative zinc finger. However, there
is an arginine-rich sequence at its C terminus (38) which, due
to its overall positive charge, may exhibit general affinity for
RNA. In addition, a centrally located region of 48K (i.e.,
amino acids 206 to 256 in humans) is highly conserved from
plants to humans (20), suggesting that it may be involved in
RNA and/or additional protein interactions.
Intron bridging in the U12-dependent prespliceosome. To
enable splicing catalysis, the functional sites of the pre-mRNA,
i.e., the 5ss, the BPS, and the 3ss, are brought into close
proximity during the earliest assembly phases of both spliceo-
somes (3, 8, 15). For the major spliceosome, SR proteins and
the DEAD box protein Prp5 have been implicated in bridging
U1 at the 5ss and U2 at the BPS in E and A complexes (40,
41). In contrast, in the minor spliceosome, U11 and U12 are
bridged by integral proteins of the U11/U12 di-snRNP,
namely, 59K and 65K, with 65K also directly interacting with
the U12 snRNA (1). Our data revealing 48K interactions with
the 5ss and 59K extend this network such that interactions
involving 48K, 59K, and 65K would bridge the 5ss and U12
bound to the BPS (Fig. 8). The link between components
interacting with the 5ss and the BPS is also consistent with the
idea that combinatorial interactions at these sites contribute to
intron recognition, as discussed above.
Implications for regulating the activity of the U12-depen-
dent spliceosome. Early protein-pre-mRNA interactions con-
tributing to intron recognition may play a decisive role in
determining which spliceosome ultimately forms on a particu-
lar intron. The posttranslational modification of proteins may
affect U12-type intron recognition directly by either enhancing
or interfering with splice site recognition or indirectly by af-
fecting di-snRNP assembly or by changing the conformation of
the complex. Intriguingly, based on the migration behavior of
the 48K protein on polyacrylamide gels, it was previously sug-
gested that the protein may be posttranslationally modified
(38). The excision of U12-type introns appears to be the rate-
limiting step in the splicing of genes containing both types of
introns (23, 25). Therefore, the posttranslational modification
of unique spliceosomal factors, such as 48K, may potentially
allow for the rapid regulation of the U12-dependent spliceo-
some and thus affect the expression of genes with U12-type
introns.
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